Authors: Slatter, JG Stalker, DJ Feenstra, KL Welshman, IR Bruss, JB Sams, JP Johnson, MG Sanders, PE Hauer, MJ Fagerness, PE Stryd, RP Peng, GW Shobe, EM

Citation: Jg. Slatter et al., Pharmacokinetics, metabolism, and excretion of linezolid following an oraldose of [C-14]linezolid to healthy human subjects, DRUG META D, 29(8), 2001, pp. 1136-1145

Authors: Hutzler, JM Hauer, MJ Tracy, TS

Citation: Jm. Hutzler et al., Dapsone activation of CYP2C9-mediated metabolism: Evidence for activation of multiple substrates and a two-site model (vol 29, pg 1029, 2001), DRUG META D, 29(8), 2001, pp. 1171-1171

Authors: Hutzler, JM Hauer, MJ Tracy, TS

Citation: Jm. Hutzler et al., Dapsone activation of CYP2C9-mediated metabolism: Evidence for activation of multiple substrates and a two-site model, DRUG META D, 29(7), 2001, pp. 1029-1034

Authors: Voorman, RL Payne, NA Wienkers, LC Hauer, MJ Sanders, PE

Citation: Rl. Voorman et al., Interaction of delavirdine with human liver microsomal cytochrome P450: Inhibition of CYP2C9, CYP2C19, and CYP2D6, DRUG META D, 29(1), 2001, pp. 41-47

Authors: Wynalda, MA Hauer, MJ Wienkers, LC

Citation: Ma. Wynalda et al., Oxidation of the novel oxazolidinone antibiotic linezolid in human liver microsomes, DRUG META D, 28(9), 2000, pp. 1014-1017

Authors: Wienkers, LC Allievi, C Hauer, MJ Wynalda, MA

Citation: Lc. Wienkers et al., Cytochrome P-450-mediated metabolism of the individual enantiomers of the antidepressant agent reboxetine in human liver microsomes, DRUG META D, 27(11), 1999, pp. 1334-1340